Pharmacy Shared Resource

Darryl Grendahl
Director

The Mayo Clinic Cancer Center Pharmacy Shared Resource (PSR) provides comprehensive pharmacy services in support of approximately 150 cancer clinical trials open to accrual and 100 clinical trials closed to accrual with ongoing patient treatment across the three Mayo campuses in Phoenix/Scottsdale, Ariz.; Jacksonville, Fla.; and Rochester, Minn. The PSR provides procurement, storage, and accountability of investigational agents assigned to the clinical trials. In addition, preparation and/or sterile admixture of cytotoxic chemotherapy, growth factors, immunomodulatory agents, antiemetics, and supportive care medication is provided.

The services of the Pharmacy Shared Resource are essential for protocol development, protocol initiation, and patient treatment on clinical trials throughout Mayo Clinic Cancer Center (MCCC). Special expertise with both investigational and commercially-available cancer therapeutic agents resides in the PSR, ensuring a uniformly high standard of safe and accurate treatment for all Mayo Clinic cancer patients. The primary usage of National Cancer Institute cancer center support grant funds provided to the PSR is to support pharmacy services for investigator-initiated projects not otherwise funded but leading toward external funding.

The main mission of the Pharmacy Shared Resource is to provide protocol development and review, investigational drug accountability, and chemotherapy admixture and dispensing services across all three MCCC campuses. The implementation of policies and procedures consistent with the American Society of Health-System Pharmacists guidelines and The Joint Commission on Accreditation of Healthcare Organizations recommendations at each site ensures regulatory compliance and provides a uniform level of safe, high quality pharmaceutical care to all Mayo Clinic cancer patients undergoing treatment in the clinical trial setting.